Healio

GRAVITY: Rosuvastatin plus ezetimibe showed greatest reductions in lipid parameters

Please provide your email address to receive an email when new articles are posted on . ATLANTA – Patients assigned to combination therapy with rosuvastatin plus ezetimibe experienced greater ...
The Trentonian

FDA Approves Althera’s Roszet (rosuvastatin and ezetimibe) Tablets, a New Oral Therapy for Powerful Cholesterol Reduction

MORRISTOWN, N.J., March 31, 2021 /PRNewswire-PRWeb/ — Althera Pharmaceuticals, a company focused on heart health, today announced the FDA approval of Roszet (rosuvastatin and ezetimibe) tablets, as an ...
The American Journal of Managed Care

Comparative Efficacy of Ezetimibe/Simvastatin, Rosuvastatin, and Atorvastatin in Uncontrolled Hyperlipidemia Patients

Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL. Treatment of ...
Healio

Rosuvastatin/ezetimibe tablet approved for LDL reduction in hyperlipidemia, HoFH

Althera announced the FDA approved its rosuvastatin/ezetimibe tablets as an adjunct to diet for treatment of elevated LDL in adults with primary nonfamilial hyperlipidemia or homozygous familial ...
Monthly Prescribing Reference

Fixed-Dose Combos of Ezetimibe/Rosuvastatin Best Rosuvastatin Monotherapy in Primary Hypercholesterolemia

(HealthDay News) — For patients with primary hypercholesterolemia, fixed-dose combination of ezetimibe plus rosuvastatin is more effective than rosuvastatin alone, according to a study published ...
JD Supra

FDA Issues Untitled Letter to Althera Pharmaceuticals for Statements Relating to ROSZET®

On June 2, 2022, the US Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) issued an untitled letter [1] to Althera Pharmaceuticals, LLC (Althera) relating to promotional ...
Medscape

Rosuvastatin plus ezetimibe gets 80% of high-risk patients to LDL cholesterol <70 mg/dL

Barcelona, Spain - The addition of ezetimibe (Zetia, Merck/Schering-Plough Pharmaceuticals) to statin therapy with rosuvastatin (Crestor, AstraZeneca) reduced LDL-cholesterol levels by 70%, allowing ...
Medscape

Statin Therapy With or Without Ezetimibe in Patients at High Risk for Cardiovascular Disease

The results of 2 studies presented at the 2006 symposium of the International Society of Atherosclerosis in Rome, Italy, have demonstrated the benefit of adding the cholesterol absorption inhibitor ...
The American Journal of Managed Care

Differences Between Clinical Trial Efficacy and Real-world Effectiveness

Aggressive lowering of low-density lipoprotein cholesterol (LDL-C) with statin therapy can reduce the incidence of morbidity and mortality from coronary heart disease (CHD) in primary and secondary ...
The Globe and Mail

AstraZeneca’s New Study on AZD0780: Potential Game-Changer for Cholesterol Treatment?

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AstraZeneca has launched a Phase 1 ...
TCTMD

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Among those with CAD, both rosuvastatin and atorvastatin are similarly effective regarding the combination of all-cause death, MI, stroke, or any coronary revascularization over 3 years, according to ...